UH researcher aims to revolutionize treatment regimens for triple-negative breast can

[News]

A researcher at the University of Houston College of Pharmacy Drug Discovery Institute is working to revolutionize treatment regimens for triple-negative breast cancer (TNBC) by proving that nebivolol, an FDA-approved drug for high blood pressure, is effective in treating it.

More... (https://www.news-medical.net/news/20240131/UH-researcher-aims-to-revolutionize-treatment-regimens-for-triple-negative-breast-cancer.aspx)